Pallas Capital Advisors LLC Purchases New Stake in Chemed Corporation $CHE

Pallas Capital Advisors LLC purchased a new stake in shares of Chemed Corporation (NYSE:CHE) in the 2nd quarter, Holdings Channel reports. The fund purchased 1,994 shares of the company’s stock, valued at approximately $929,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. TD Asset Management Inc raised its holdings in Chemed by 7.5% in the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company’s stock valued at $138,860,000 after acquiring an additional 22,715 shares during the period. BNP Paribas Financial Markets boosted its holdings in shares of Chemed by 14.5% during the fourth quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company’s stock worth $14,985,000 after acquiring an additional 4,430 shares during the period. Epoch Investment Partners Inc. boosted its holdings in shares of Chemed by 4.9% during the fourth quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company’s stock worth $137,945,000 after acquiring an additional 15,133 shares during the period. Abacus FCF Advisors LLC acquired a new position in shares of Chemed in the fourth quarter valued at approximately $5,935,000. Finally, C WorldWide Group Holding A S bought a new position in shares of Chemed during the fourth quarter worth approximately $2,189,000. 95.85% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on CHE shares. Oppenheimer lifted their price target on Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a report on Friday, July 31st. Weiss Ratings raised Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Royal Bank Of Canada increased their price objective on Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 30th. Bank of America reissued a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. Finally, Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a research report on Saturday, August 1st. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, Chemed presently has an average rating of “Hold” and an average price target of $530.75.

Chemed Stock Performance

Shares of NYSE:CHE opened at $529.93 on Wednesday. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $557.00. The company’s 50 day moving average price is $492.50 and its two-hundred day moving average price is $444.25. The firm has a market cap of $6.93 billion, a PE ratio of 26.62, a PEG ratio of 2.02 and a beta of 0.51. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The firm’s quarterly revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the business earned $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities research analysts predict that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be issued a $0.70 dividend. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 annualized dividend and a yield of 0.5%. This is a boost from Chemed’s previous quarterly dividend of $0.60. Chemed’s payout ratio is presently 12.05%.

Insider Buying and Selling at Chemed

In other news, Director Andrea R. Lindell sold 1,347 shares of the company’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director directly owned 4,578 shares in the company, valued at approximately $2,047,876.74. This represents a 22.73% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Patrick P. Grace sold 190 shares of the stock in a transaction on Friday, July 31st. The stock was sold at an average price of $532.00, for a total value of $101,080.00. Following the sale, the director directly owned 3,533 shares in the company, valued at approximately $1,879,556. This trade represents a 5.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 3,537 shares of company stock valued at $1,782,654 in the last three months. Corporate insiders own 3.33% of the company’s stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.